CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Reconciliation of net loss to cash used by operating activities:
Net loss	$ (9,064)	$ (11,344)
Add (deduct):
Depreciation and amortization	8,306	7,105
Provision for bad debt	711	449
Investment and other gains – net	(488)	(1,151)
Payments for title losses less than provisions	101	12,654
Insurance recoveries of title losses	312	263
Increase in receivables – net	(4,246)	(13,476)
Increase in other assets – net	(2,583)	(5,527)
Decrease in payables and accrued liabilities – net	(28,540)	(14,501)
Decrease in net deferred income taxes	(1,953)	(2,222)
Net income from equity investees	(341)	(588)
Dividends received from equity investees	581	694
Stock based compensation expense	1,395	1,044
Other – net	3,968	(270)
Cash used by operating activities	(31,841)	(26,870)
Investing activities:
Proceeds from investments available-for-sale sold	11,327	23,901
Proceeds from investments available-for-sale matured	260	9,802
Purchases of investments available-for-sale	(44,254)	(33,468)
Net purchases of short-term investments	(2,302)	(247)
Purchases of property and equipment, title plants and real estate – net	(5,494)	(4,979)
Cash paid for acquisition of subsidiaries	0	(3,958)
Other – net	387	543
Cash used by investing activities	(40,076)	(8,406)
Financing activities:
Payments on notes payable	(1,307)	(5,951)
Proceeds from notes payable	10,000	0
Distributions to noncontrolling interests	(3,028)	(1,677)
Repurchases of common stock	0	(1,393)
Cash dividends paid	(6,720)	0
Other – net	(240)	98
Cash used by financing activities	(1,295)	(8,923)
Effects of changes in foreign currency exchange rates	2,898	(3,213)
Decrease in cash and cash equivalents	(70,314)	(47,412)
Cash and cash equivalents at beginning of period	179,067	200,558
Cash and cash equivalents at end of period	$ 108,753	$ 153,146